Q2
BBNX — Q2 2026 Financial Report Analysis
Beta Bionics grew Q2 2026 net sales 38% to $32.0M as supplies doubled and gross margin rose to 59.0%, but a 58% rise in sales and marketing widened the net loss to $23.4M; full-year guidance was later cut ahead of the Mint patch pump launch.